{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T10:12:46Z","timestamp":1768644766577,"version":"3.49.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"DOI":"10.7759\/cureus.101702","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T22:09:06Z","timestamp":1768601346000},"source":"Crossref","is-referenced-by-count":0,"title":["Chronic Plaque Psoriasis With Persistent Facial Involvement Successfully Treated With Risankizumab: A Case Report"],"prefix":"10.7759","author":[{"given":"Reem","family":"AlQusaimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawziah","family":"AlRujaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"AlSharhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suad","family":"Alassaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layal","family":"Khoursheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemah","family":"Abdulrahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa","family":"AlAwadhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke WH","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP. Psoriasis. Lancet. 2015, 386:983-94. 10.1016\/s0140-6736(14)61909-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112427","article-title":"Treatment approaches to moderate to severe psoriasis","volume":"18","author":"Gisondi P","year":"2017","unstructured":"Gisondi P, Del Giglio M, Girolomoni G. Treatment approaches to moderate to severe psoriasis. Int J Mol Sci. 2017, 18:2427. 10.3390\/ijms18112427","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths CEM","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021, 397:1301-15. 10.1016\/s0140-6736(20)32549-6","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17723","article-title":"The required absolute PASI score to achieve DLQI remission","volume":"52","author":"Nishida E","year":"2025","unstructured":"Nishida E, Morita A. The required absolute PASI score to achieve DLQI remission. J Dermatol. 2025, 52:947-9. 10.1111\/1346-8138.17723","journal-title":"J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.23736\/S2784-8671.24.07979-9","article-title":"Facial psoriasis treated with tildrakizumab","volume":"160","author":"Trovato E","year":"2025","unstructured":"Trovato E, Dragotto M, Capalbo E, Lamberti A, Rubegni P. Facial psoriasis treated with tildrakizumab. Ital J Dermatol Venerol. 2025, 160:70-1. 10.23736\/S2784-8671.24.07979-9","journal-title":"Ital J Dermatol Venerol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","volume":"80","author":"Menter A","year":"2019","unstructured":"Menter A, Strober BE, Kaplan DH, et al.. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019, 80:1029-72. 10.1016\/j.jaad.2018.11.057","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19547","article-title":"Pulsed dye laser for facial erythema in Netherton syndrome","volume":"38","author":"Smets G","year":"2024","unstructured":"Smets G, Gutermuth J, Grosber M, Baharlou S. Pulsed dye laser for facial erythema in Netherton syndrome. J Eur Acad Dermatol Venereol. 2024, 38:e229-30. 10.1111\/jdv.19547","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/457262-chronic-plaque-psoriasis-with-persistent-facial-involvement-successfully-treated-with-risankizumab-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T22:09:07Z","timestamp":1768601347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/457262-chronic-plaque-psoriasis-with-persistent-facial-involvement-successfully-treated-with-risankizumab-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.101702","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,16]]}}}